Cargando…

Effects of Different Types of COVID-19 Vaccines on Menstrual Cycles of Females of Reproductive Age Group (15-49): A Multinational Cross-Sectional Study

Background Globally, there are more than 474 million cases and around 6 million deaths due to COVID-19. The case fatality rate was 0.5-2.8% while for 80-89 years old, it was 3.7-14.8%. Given the seriousness of this infection, prevention becomes critical. Hence, the introduction of vaccines led to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Filfilan, Nuha N, Bukhari, Suhaib, Rizwan, Maryam, Bukhari, Nirmeen M, Aref, Nisreen K, Arain, Farzana R, Alabbadi, Ibrahim K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306122/
https://www.ncbi.nlm.nih.gov/pubmed/37388582
http://dx.doi.org/10.7759/cureus.39640
_version_ 1785065871225389056
author Filfilan, Nuha N
Bukhari, Suhaib
Rizwan, Maryam
Bukhari, Nirmeen M
Aref, Nisreen K
Arain, Farzana R
Alabbadi, Ibrahim K
author_facet Filfilan, Nuha N
Bukhari, Suhaib
Rizwan, Maryam
Bukhari, Nirmeen M
Aref, Nisreen K
Arain, Farzana R
Alabbadi, Ibrahim K
author_sort Filfilan, Nuha N
collection PubMed
description Background Globally, there are more than 474 million cases and around 6 million deaths due to COVID-19. The case fatality rate was 0.5-2.8% while for 80-89 years old, it was 3.7-14.8%. Given the seriousness of this infection, prevention becomes critical. Hence, the introduction of vaccines led to a significant reduction (> 75% protection) in COVID-19 cases. On the other hand, patients seeking help for serious pulmonary, cardiovascular, neurological, and gynecological complaints have also been recorded. Clinical studies on the effects of vaccination focused mostly on life-or-death results rather than reproductive outcomes such as menstruation, fertility, or even pregnancy outcomes. This survey was conducted to get more evidence on the association between menstrual cycle irregularities and some globally most prevalent COVID-19 vaccines. Methods An online cross-sectional survey was conducted by a team from Taif University, Kingdom of Saudi Arabia, from January to June 2022 on females within the reproductive age group (15-49 years) using a semi-structured questionnaire. Data were analyzed using SPSS Statistics version 22.0 and presented as frequency and percentage. The chi-square test was applied for the association and a p-value of <0.05 was considered significant. Results A total of 2381 responses were included. The mean age of respondents was 25±7.7 years. Around 1604 (67%) participants observed post-vaccination menstrual changes, and the findings were significant (p< 0.001). A strong association (p=.008) was found between the type of vaccine and changes in the menstrual cycle in participants (AstraZeneca 11 (36%)) after one dose. A strong association (p=.004) was also seen between the type of vaccine (Pfizer 543 (83%)) and menstrual changes after the booster dose. Cycles became irregular 180 (36%) or prolonged 144 (29%) in females inoculated with Pfizer after two doses of vaccination (p=0.012). Conclusion Post-vaccination menstrual irregularities were reported by females of reproductive age, especially the new vaccines. Prospective studies for similar insights are needed. Finding the co-occurring impacts of vaccination and COVID-19 infections in the wake of the emerging new long-haul COVID-19 phenomena is crucial for reproductive health.
format Online
Article
Text
id pubmed-10306122
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-103061222023-06-29 Effects of Different Types of COVID-19 Vaccines on Menstrual Cycles of Females of Reproductive Age Group (15-49): A Multinational Cross-Sectional Study Filfilan, Nuha N Bukhari, Suhaib Rizwan, Maryam Bukhari, Nirmeen M Aref, Nisreen K Arain, Farzana R Alabbadi, Ibrahim K Cureus Obstetrics/Gynecology Background Globally, there are more than 474 million cases and around 6 million deaths due to COVID-19. The case fatality rate was 0.5-2.8% while for 80-89 years old, it was 3.7-14.8%. Given the seriousness of this infection, prevention becomes critical. Hence, the introduction of vaccines led to a significant reduction (> 75% protection) in COVID-19 cases. On the other hand, patients seeking help for serious pulmonary, cardiovascular, neurological, and gynecological complaints have also been recorded. Clinical studies on the effects of vaccination focused mostly on life-or-death results rather than reproductive outcomes such as menstruation, fertility, or even pregnancy outcomes. This survey was conducted to get more evidence on the association between menstrual cycle irregularities and some globally most prevalent COVID-19 vaccines. Methods An online cross-sectional survey was conducted by a team from Taif University, Kingdom of Saudi Arabia, from January to June 2022 on females within the reproductive age group (15-49 years) using a semi-structured questionnaire. Data were analyzed using SPSS Statistics version 22.0 and presented as frequency and percentage. The chi-square test was applied for the association and a p-value of <0.05 was considered significant. Results A total of 2381 responses were included. The mean age of respondents was 25±7.7 years. Around 1604 (67%) participants observed post-vaccination menstrual changes, and the findings were significant (p< 0.001). A strong association (p=.008) was found between the type of vaccine and changes in the menstrual cycle in participants (AstraZeneca 11 (36%)) after one dose. A strong association (p=.004) was also seen between the type of vaccine (Pfizer 543 (83%)) and menstrual changes after the booster dose. Cycles became irregular 180 (36%) or prolonged 144 (29%) in females inoculated with Pfizer after two doses of vaccination (p=0.012). Conclusion Post-vaccination menstrual irregularities were reported by females of reproductive age, especially the new vaccines. Prospective studies for similar insights are needed. Finding the co-occurring impacts of vaccination and COVID-19 infections in the wake of the emerging new long-haul COVID-19 phenomena is crucial for reproductive health. Cureus 2023-05-29 /pmc/articles/PMC10306122/ /pubmed/37388582 http://dx.doi.org/10.7759/cureus.39640 Text en Copyright © 2023, Filfilan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Obstetrics/Gynecology
Filfilan, Nuha N
Bukhari, Suhaib
Rizwan, Maryam
Bukhari, Nirmeen M
Aref, Nisreen K
Arain, Farzana R
Alabbadi, Ibrahim K
Effects of Different Types of COVID-19 Vaccines on Menstrual Cycles of Females of Reproductive Age Group (15-49): A Multinational Cross-Sectional Study
title Effects of Different Types of COVID-19 Vaccines on Menstrual Cycles of Females of Reproductive Age Group (15-49): A Multinational Cross-Sectional Study
title_full Effects of Different Types of COVID-19 Vaccines on Menstrual Cycles of Females of Reproductive Age Group (15-49): A Multinational Cross-Sectional Study
title_fullStr Effects of Different Types of COVID-19 Vaccines on Menstrual Cycles of Females of Reproductive Age Group (15-49): A Multinational Cross-Sectional Study
title_full_unstemmed Effects of Different Types of COVID-19 Vaccines on Menstrual Cycles of Females of Reproductive Age Group (15-49): A Multinational Cross-Sectional Study
title_short Effects of Different Types of COVID-19 Vaccines on Menstrual Cycles of Females of Reproductive Age Group (15-49): A Multinational Cross-Sectional Study
title_sort effects of different types of covid-19 vaccines on menstrual cycles of females of reproductive age group (15-49): a multinational cross-sectional study
topic Obstetrics/Gynecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306122/
https://www.ncbi.nlm.nih.gov/pubmed/37388582
http://dx.doi.org/10.7759/cureus.39640
work_keys_str_mv AT filfilannuhan effectsofdifferenttypesofcovid19vaccinesonmenstrualcyclesoffemalesofreproductiveagegroup1549amultinationalcrosssectionalstudy
AT bukharisuhaib effectsofdifferenttypesofcovid19vaccinesonmenstrualcyclesoffemalesofreproductiveagegroup1549amultinationalcrosssectionalstudy
AT rizwanmaryam effectsofdifferenttypesofcovid19vaccinesonmenstrualcyclesoffemalesofreproductiveagegroup1549amultinationalcrosssectionalstudy
AT bukharinirmeenm effectsofdifferenttypesofcovid19vaccinesonmenstrualcyclesoffemalesofreproductiveagegroup1549amultinationalcrosssectionalstudy
AT arefnisreenk effectsofdifferenttypesofcovid19vaccinesonmenstrualcyclesoffemalesofreproductiveagegroup1549amultinationalcrosssectionalstudy
AT arainfarzanar effectsofdifferenttypesofcovid19vaccinesonmenstrualcyclesoffemalesofreproductiveagegroup1549amultinationalcrosssectionalstudy
AT alabbadiibrahimk effectsofdifferenttypesofcovid19vaccinesonmenstrualcyclesoffemalesofreproductiveagegroup1549amultinationalcrosssectionalstudy